About The Program
Novel Approaches to Haematological Diseases (NAHD) is part of the program entitled Accelerating the application of Stem cell technology in Human Disease (ASHD), an Indo-Japan collaborative project, supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India. This program aims to exploit cutting-edge biotechnology applied to stem cell science and human genetics to range of clinical applications including gene therapy for haematological diseases to address several unmet needs in the country. The major components of the NAHD program are (i) Gene Therapy for the common hereditary haematological disorders such as thalassemia major, sickle cell disease and haemophilia (ii) Haplobanking to create a cell bank of HLA haplo-identical induced pluripotent stem cells for regenerative medicine and (iii) Establishing a model for the control and prevention of thalassemia major and sickle cell disease in the community.